Review a dermatologist's advice on sun protection, retinoids and collagen supplements, with evidence limits and safety cautions kept clear.
On October 27, 2026, NDTV reported advice from dermatologist Gurveen Waraich Garekar on supporting skin collagen as it declines with age. Her comments drew a useful distinction: protecting existing collagen is a different goal from encouraging new collagen production.
The report addressed collagen’s popularity in skincare products, supplements and treatments. For readers weighing those choices, the important question is not simply whether something is described as supporting collagen. It is which outcome is being claimed and what evidence supports that claim.
In NDTV’s account, Garekar separated skincare measures by their intended role:
This distinction offers a useful way to read product claims. A claim about preserving collagen addresses a different question from a claim about producing more of it. Keeping the intended outcome clear makes it easier to understand the advice without treating all collagen-related products as equivalent.
Retinoids also have support from a separate dermatology authority. The American Academy of Dermatology says they can boost collagen and reduce fine lines and wrinkles. That guidance provides a firmer basis for discussing retinoids than relying on an ingredient’s appearance in a collagen-focused product description alone.
Hydration belongs in a separate category. Garekar discussed it as a possible benefit of collagen supplements. A statement about skin hydration should therefore be read as a hydration claim rather than automatically translated into a claim about new collagen.
That distinction is worth keeping in mind when assessing competing collagen claims. The word “collagen” may connect the discussion, but the outcomes still need to be considered separately.
Secondary reporting on a 2025 meta-analysis described an overall evidence pool of 23 randomized trials involving 1,474 participants. The review examined skin outcomes including hydration, elasticity and wrinkles.
According to that coverage, results were not statistically significant when analyses were restricted to higher-quality studies or studies without pharmaceutical-company funding. Positive pooled findings therefore did not remain statistically significant in those restricted analyses.
The distinction matters. A combined result across all included studies is not the same as a result that remains convincing when study quality and funding are considered. The overall participant total also should not be mistaken for the size of each restricted subset.
These findings do not establish that no individual could experience a benefit. They do make broad claims of reliable improvement harder to support. Controlled-trial results also do not guarantee the same experience in an everyday routine.
NDTV’s article reports a dermatologist’s recommendations rather than a comparative clinical trial. It does not provide trial methods, product formulations or effect sizes for the skincare and lifestyle measures discussed. It therefore offers no basis for calculating how much collagen a particular routine would preserve or produce.
The supporting sources are also uneven across ingredient categories. The AAD guidance supports collagen-related effects for retinoids, but it does not independently substantiate the report’s claims about peptides or vitamin C. Those claims remain Garekar’s reported advice rather than independently established conclusions within this evidence base.
Exercise deserves the same careful attribution. NDTV quoted Garekar describing the evidence for strength training as “very strong.” The article did not identify the underlying exercise studies or quantify an effect on skin collagen.
For supplements, Garekar said the evidence for building new collagen was “not very strong.” The meta-analysis figures above come from secondary reporting rather than an independent assessment of the original paper. Its reported hydration and appearance outcomes should not be relabeled as proof of new collagen production.
These boundaries keep the interpretation specific: the report supplies a useful clinical perspective, while leaving product-level comparisons and the size of any expected benefit unresolved.
The clearest practical message is to prioritize sun protection rather than organize every skincare decision around a collagen-building promise. Sunscreen appears in Garekar’s recommendations and in the AAD’s retinoid guidance. It is a shared point across the sources rather than a conclusion resting on supplement publicity.
This fits a broader approach to keeping preventive skincare grounded in everyday habits. The useful question is whether a measure addresses a supported goal, not whether its marketing uses the most ambitious language.
Retinoid decisions require individualized care. The AAD warns that retinoids can make skin more sun-sensitive. Its guidance recommends gradual use to limit irritation and daytime sun protection. These cautions belong alongside the discussion of potential benefits rather than being treated as an afterthought.
The AAD advises against retinoid use during pregnancy. It also notes that people with skin allergies, dryness or significant redness or inflammation may not be good candidates without clinical guidance. A qualified clinician can help assess personal suitability rather than assuming that a collagen-related benefit makes an ingredient appropriate for everyone.
Garekar’s broader recommendations included adequate dietary protein, a balanced diet and enough sleep. Those suggestions place skincare within a wider health context. They do not require turning every meal or daily habit into a collagen-focused intervention.
For supplement decisions, the practical distinction is to identify the promised outcome before weighing the product. A hydration claim and a claim about new collagen should not be accepted as interchangeable. Personal questions about suitability belong with qualified care rather than a general news report.
Garekar’s advice is most useful as a framework for reading claims rather than a universal collagen regimen. Protection, production and hydration are different goals. Each deserves evidence that matches the wording used to describe it.
The open research question is whether specific interventions produce meaningful benefits that remain convincing in stronger studies. For now, the measured takeaway is to keep sun protection central and discuss retinoids with appropriate clinical guidance. The next collagen headline is easier to judge when its promised outcome is clear.
Stay connected for research and practical guidance on skin, hair, collagen, nutrition and beauty longevity. Clear ideas for people who want to understand how appearance changes with age and make better-informed choices over time.
Understand your skin, hair and body better without chasing every new trend, treatment or promise.
explore the Blog
